F erritin is a key protein in iron metabolism. Its involvement in iron detoxification and iron storage is known, but recently, a new role in the pathogenesis of different autoimmune and autoinflammatory syndromes was hypothesized [1]. Four immune mediated conditions sharing the feature of marked hyperferritinemia have been gathered under the single term “Hyperferritinemic Syndromes” [1]. Such syndromes include macrophage activation syndrome (MAS), catastrophic antiphospholipid syndrome (CAPS), septic shock, and adultonset Still’s disease (AOSD). These conditions constitute the scenario of the so-called cytokine storm and share a marked hyperferritinemia as well as clinical and laboratory features. As far as we know, with regard to its structure, ferritin is composed of two different subunits, H and L, whose ratio is not fixed as it varies among several inflammatory and infectious conditions. Ferritin in spleen and liver, as well as in serum, is largely composed of L-subunits (involved in iron storage), while in heart and kidney the H-subunits (involved in iron detoxification) are predominant. Recently, an increase in the H-subunit expression, driven by different inflammatory stimuli, was demonstrated [2]. Furthermore, a possible role for ferritin in the regulation of immune response was suggested by Recalcati et al. in 2008 [3]. Indeed, the H-ferritin subunit can inhibit lymphoid and myeloid cell proliferation; and a specific ferritin receptor named TIM2, present on several immune effector cells in murine models, has been identified [4]. Ruddell et al. reported in 2009 [5] that ferritin may behave similarly to pro-inflammatory cytokines, binding to the TIM-2 receptor in hepatic cell media. In doing so it may activate the hepatic cells, inducing enhanced production of several cytokines such as interleukin (IL)-1β. With regard to its production, ferritin synthesis is induced by several inflammatory stimuli including cytokines IL-1α, IL-1β, IL-18, tumor necrosis factor-alpha (TNFα), interferongamma (IFNγ), macrophage-colony stimulating factor (M-CSF) and IL-6. It was initially believed that the main passive source of ferritin was its leakage from damaged cells during inflammatory conditions. Ghosh et al. [6] later described an active production of ferritin L-subunit through a classical secretory pathway. More recently, Cohen et al. [7] reported the significant contribution of macrophages in ferritin production owing to the proven ability of these cells to actively secrete this protein through a non-classical secretory pathway. Such findings support the idea of active production of ferritin in the course of specific autoinflammatory conditions and, thus, a possible role other than second acute inflammatory reactant.
[1]
R. Priori,et al.
Interleukin 18: A Biomarker for Differential Diagnosis Between Adult-onset Still’s Disease and Sepsis
,
2014,
The Journal of Rheumatology.
[2]
Y. Shoenfeld,et al.
The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome
,
2013,
BMC Medicine.
[3]
B. Mehta,et al.
Ferritin in Adult-Onset Still's Disease: Just a Useful Innocent Bystander?
,
2012,
International journal of inflammation.
[4]
A. Mantovani,et al.
Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype.
,
2011,
Trends in immunology.
[5]
M. Hentze,et al.
Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway.
,
2010,
Blood.
[6]
D. Watters,et al.
Ferritin functions as a proinflammatory cytokine via iron‐independent protein kinase C zeta/nuclear factor kappaB–regulated signaling in rat hepatic stellate cells
,
2009,
Hepatology.
[7]
P. Arosio,et al.
New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity.
,
2008,
Journal of autoimmunity.
[8]
F. Brodsky,et al.
TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis
,
2005,
The Journal of experimental medicine.
[9]
Sharmistha Ghosh,et al.
Regulated secretion of glycosylated human ferritin from hepatocytes.
,
2004,
Blood.
[10]
K. Myambo,et al.
The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene.
,
1988,
The Journal of biological chemistry.